Send us Feedback

Ligand Pharmaceuticals (LGND)
Analysis
SUMMARY
BULLS
BEARS
TOPICS
Data
DATA CENTRAL
STOCK CHART
Financials
SEC FILINGS
BALANCE
INCOME
CASH FLOW
QUOTE AND NEWS
CORRECTING and REPLACING Ligand to Present at the Jefferies 2012 Global Healthcare Conference on June 4
Business Wire  May 14  Comment 
Conference in headline and first graph, first sentence of release should read: Jefferies 2012 Global Healthcare Conference (sted 2011). The corrected release reads: LIGAND TO PRESENT AT THE JEFFERIES 2012 GLOBAL HEALTHCARE CONFERENCE ON JUNE 4 Ligand
Ligand to Present at the Bank of America Merrill Lynch 2012 Health Care Conference on May 17
Business Wire  May 7  Comment 
Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) announced today that John Higgins, President and Chief Executive Officer will present at the Bank of America Merrill Lynch 2012 Health Care Conference on Thursday, May 17, 2012 at 8:00 a.m. Pacific
Ligand Pharmaceuticals, Inc. (LGND) Tops Q1 EPS by 9c
StreetInsider.com  May 2  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Earnings/Ligand+Pharmaceuticals%2C+Inc.+%28LGND%29+Tops+Q1+EPS+by+9c/7396070.html for the full story.
Ligand Pharmaceuticals Reports First Quarter Results
Business Wire  May 2  Comment 
Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) today reported financial results for the first quarter ended March 31, 2012, and provided an operating forecast and program updates. "2012 has opened strong for Ligand and our partnered programs. GSK
Ligand to Report First Quarter Results on May 2nd
Business Wire  Apr 16  Comment 
Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) announced today plans to report first quarter 2012 financial results on Wednesday, May 2, 2012. Ligand’s President and CEO, John L. Higgins, Executive Vice President and COO, Matt Foehr and Vice
Ligand to Present at the 24th Annual Roth Conference on March 12
Business Wire  Mar 5  Comment 
Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) announced today that John Higgins, President and Chief Executive Officer and Matt Foehr, Chief Operating Officer and Executive Vice President of Ligand, will present at the 24th Annual Roth
Ligand to Present at the Citi Global Health Care Conference on February 28th
Business Wire  Feb 21  Comment 
Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) announced today that John Higgins, President and Chief Executive Officer of Ligand, will present at the Citi Global Health Care Conference on Tuesday, February 28, 2012 at 12:00 p.m. Pacific (3:00
Ligand Licenses DARA Program to Retrophin; Potential For Over $75 Million In Milestone Payments to Ligand Plus Royalties
Benzinga  Feb 21  Comment 
Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) and Retrophin, LLC announced that the companies have entered into an agreement in which Ligand has licensed rights to DARA (a Dual Acting Receptor Antagonist of Angiotensin and Endothelin...
Ligand (LGND) Licenses DARA to Retrophin; May Get Up to $75M in Milestone Payments
StreetInsider.com  Feb 21  Comment 
MLV & Co Affirms Ligand Pharmaceuticals Buy, $30 PT
Benzinga  Feb 8  Comment 
MLV & Co affirms its Buy rating and $30 price target on Ligand Pharmaceuticals (NASDAQ: LGND) following the company's earnings results in a research report out today. In the report, MLV & Co writes, "On February 8, after market close, LGND...
Ligand Pharma (LGND) Completes PG-Free Melphalan Phase II, Issues Update
StreetInsider.com  Feb 2  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Ligand+Pharma+%28LGND%29+Completes+PG-Free+Melphalan+Phase+II%2C+Issues+Update/7129474.html for the full story.




more ▼WIKI ANALYSIS
 The article on this company has not been written yet. If you're the first person to write this article, it's a sure thing that you'll be credited as a Top Contributor. For tips on getting started, check out the sample article.


You may also be interested in articles related to Ligand Pharmaceuticals (LGND):
 




References

Retrieved from "http://www.wikinvest.com/stock/Ligand_Pharmaceuticals_(LGND)"
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki